Opendata, web and dolomites
H2020 projects about "cancers"
The page lists 339 projects related to the topic "cancers".
| # | |||
|---|---|---|---|
| 1 | FORECEE | Female cancer prediction using cervical omics to individualise screening and prevention | 2015 |
| 2 | EU-TOPIA | EU-TOPIA: TOWARDS IMPROVED SCREENING FOR BREAST, CERVICAL AND COLORECTAL CANCER IN ALL OF EUROPE | 2015 |
| 3 | GLAM | Laser Multiplexed Biosensor | 2015 |
| 4 | EPICUP | Development of a ncRNA DNA Methylation Kit for the Diagnosis of Cancer of Unknown Primary | 2015 |
| 5 | COLOStage | COLOStage : A new prognosis test for the prediction of metastasis in Colorectal Cancer and Hepatocellular Carcinoma | 2015 |
| 6 | Cancer-Targeted PolyIC | Treatment of EGFR over-expressing cancers by targeted non-viral delivery of PolyIC | 2015 |
| 7 | MEL-PLEX | Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine | 2014 |
| 8 | RINGE3 | Structural and mechanistic insights into RING E3-mediated ubiquitination | 2015 |
| 9 | GLYCO-TOOLS | Bio-Inspired Tools for Glycoscience | 2015 |
| 10 | CVDTEU | Clinical validation of the DiviTum assay in key European markets | 2014 |
| 11 | Cancer-Drug-Screen | High-throughput drug screening for identifying personalized cancer treatments tailored to the particular mutations of the patient’s tumor | 2015 |
| 12 | CANCER-TECH | Cervical cancer detection platform based on novel laser processing | 2016 |
| 13 | mini-liver SCCS | Human “mini-liver” stem cell culture systems: from mechanisms behind liver cancer origin and recurrence to new therapeutic treatments | 2016 |
| 14 | NIMBLIS | Laser Induced Synthesis of Biocompatible Multifunctional Inorganic Nanoparticles: A Novel Route to Produce Multifunctional Contrast Agents for Early Diagnosis of Breast Cancer | 2016 |
| 15 | STROMAMECH | Targeting stromal cells to modify tumor mechanical microenvironment and optimize drug delivery | 2015 |
| 16 | DC cancer | Development and immunological control of dendritic cell cancer | 2015 |
| 17 | SilentFACT | Functional networks and cancer roles of the essential histone chaperone FACT | 2015 |
| 18 | ChemoBOOM | Development of Palladium-Labile Prodrugs for Bioorthogonally-Activated Chemotherapy | 2016 |
| 19 | RISH | Imaging of multiple mRNA targets using SERS nanoparticle labels and in situ hybridization in human cancer tissue sections | 2015 |
| 20 | ACM | Cholesterol metabolism as a driver of prostate cancer aggressiveness | 2015 |
| 21 | EGFR-Activ | Epidermal growth factor receptor (EGFR) activation by cytohesins - Structural Insights | 2015 |
| 22 | CELLETEST | Liquid Biopsy blood test in lung cancer diagnosis and monitoring: a next generation noninvasive tumor tracker device | 2015 |
| 23 | HYMEDNA | Hypermethylated DNA detection using NanoGaps | 2015 |
| 24 | SUMOblock | Blocking SUMO conjugation as drug discovery strategy. | 2015 |
| 25 | URO-BEST | UROthelial carcinoma Biomarker based diagnostic tEST | 2015 |
| 26 | MEDICIS-PROMED | MEDICIS-produced radioisotope beams for medicine | 2015 |
| 27 | INPACT | Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication. | 2015 |
| 28 | VIRION | Viruses, Immune stimulation and RNA Interference in Oncology Network | 2015 |
| 29 | RAIL | Radiomics of lung cancer (RAIL): non-invasive stratification of tumour heterogeneity for personalised cancer therapy | 2015 |
| 30 | ER_disease | Defining hormonal cross-talk and the role of mutations in estrogen receptor positive breast cancer | 2015 |
| 31 | PERSYST | Generation and maintenance of long-lived memory T cells in humans | 2015 |
| 32 | MELGEN | MELanoma GENetics - understanding and biomarking the genetic and immunological determinants of melanoma survival | 2015 |
| 33 | MammaPrint | Improved breast cancer care by innovative diagnostic test MammaPrint | 2015 |
| 34 | BLACANDI | BLACANDI can improve life quality and cut cost of diagnosing and managing bladder cancer in half | 2015 |
| 35 | IRSkin | IRSkin provides dermatologists a new dermatoscope, equipped with a software for visual comparisons in the diagnostic phase, performing a content based Image Retrieval from an a-priori built database. | 2015 |
| 36 | DERMAE | Clinical research for the validation of a non-invasive medical imaging device for dermatological diagnoses | 2015 |
| 37 | LAUREN | bLadder cAncer URine cEll aNalysis | 2015 |
| 38 | MetCAF | Uncovering the Role of Cancer Associated Fibroblasts in Facilitating Breast Cancer Metastasis | 2015 |
| 39 | SPICE | Synthetic Lethal Phenotype Identification through Cancer Evolution Analysis | 2015 |
| 40 | NuFEAST | Optimising Nutritional Health and Wellbeing Through Local Sustainable Food Systems -NuFEAST (Nutrition - Food (for) Everyone's health, Available, Sustainable and Trusted) | 2015 |
| 41 | LEGO | Multimodal glycoconjugates: a molecular Lego approach for antitumoral immunotherapy | 2015 |
| 42 | Drug-Seq | Unravelling the Genomic Targets of Drugs Using High-Throughput Sequencing | 2015 |
| 43 | DNA2REPAIR | DNA strand break repair and links to human disease | 2015 |
| 44 | PHII | PTX3 in Humoral Innate Immunity | 2015 |
| 45 | Phd | Deciphering PI3K biology in health and disease | 2015 |
| 46 | HaemMetabolome | Deciphering the Metabolism of Haematological Cancers | 2015 |
| 47 | IL7sigNETure | IL-7/IL-7R signaling networks in health and malignancy | 2015 |
| 48 | MMUVR | Elucidating the role of ultraviolet radiation in melanoma | 2016 |
| 49 | EPOCH28 | Epigenetic Profiling of Chemotherapy Efficacy | 2015 |
| 50 | ONCOCHECK | A simple blood test to monitor disease progression in patients undergoing cancer therapy | 2015 |
| 51 | CANDLE | Cancer Diagnosis by Multiplex Protein Epitope Profiling | 2015 |
| 52 | MaXIMA | Three dimensional breast cancer models for X-ray Imaging research | 2016 |
| 53 | ARVisS | Augmented Reality Vision for Surgery | 2015 |
| 54 | MAIN | Molecular Adhesion and Interactions in the Nervous system | 2016 |
| 55 | PanCaT | Next-generation in vivo models for improved pancreatic cancer therapies | 2016 |
| 56 | HEP-CAR | Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities. | 2016 |
| 57 | ChiLTERN | Children’s Liver Tumour European Research Network | 2016 |
| 58 | Bcl-Inhib | Discovery of Bcl-3 inhibitors as Potential Chemopreventive Agent for skin cancer | 2015 |
| 59 | BD2Decide | Big Data and models for personalized Head and Neck Cancer Decision support | 2016 |
| 60 | PEPTO1 | Feasibility study of a novel treatment for cancer based on a recombinant peptide therapy | 2016 |
| 61 | LDC4PCaTher | BMX-targeted ligand-drug conjugates for prostate cancer therapy | 2016 |
| 62 | ThruBlood | Clinical validation of Trop-2 as a serum biomarker for monitoring of disease-course in patients affected by breast and colon cancer | 2016 |
| 63 | PolyDomFormFuncReg | Discovering how polycomb domains form and function in gene regulation | 2016 |
| 64 | NoCanTher | Nanomedicine upscaling for early clinical phases of multimodal cancer therapy | 2016 |
| 65 | IMAGINE | Widefield Raman imaging probe for intraoperative margin assessment of cancers | 2016 |
| 66 | EnterTerra | Transcriptional regulation and mechanistic insights on the telomeric lncRNA TERRA | 2016 |
| 67 | iGEMMdev | Development and Characterisation of New Immunogenic GEMMs of Lung Cancer | 2017 |
| 68 | SLIM | Synthetic Lethal Interactions with nucleophosMin 1 | 2016 |
| 69 | PDA_TGFb | TGF-beta mediated crosstalk between cancer (stem) cells and tumor microenvironment in pancreatic cancer metastasis | 2017 |
| 70 | RecInRep | Beyond double-strand break repair: specific mechanisms of homologous recombination at stressed replication forks. | 2016 |
| 71 | OMIS | Feasibility study on Opto-Magnetic Imaging Spectroscopy for cancer screening | 2016 |
| 72 | NEBU-ONE | NEBU-ONE : A revolutionary method for anatomic pathology slides staining | 2016 |
| 73 | RETINAL | Retinal Imaging prevention and early detection of chronic diseases | 2016 |
| 74 | iBILD | iBILD: Imaging Biomarker for Intelligent Lung Cancer Detection | 2016 |
| 75 | LDMBI | Low dose Molecular Breast Imaging for improved cancer detection in dense breast tissue. | 2016 |
| 76 | MRCKa in cancer | Targeting Cancer Cell Invasion and Metastasis by Inhibition of the Serine Kinase MRCKa | 2016 |
| 77 | SYNVIA | Synthetic viability of homologous recombination-deficient cancers | 2016 |
| 78 | VIBRANT-BIO | High-throughput vibrational fingerprinting by nanoplasmonics for disease biology | 2017 |
| 79 | NANOZ-ONIC | Bio-inspired electrONIC NOSE interfacing olfactory electrical biosensors and carbon NANOtubes | 2016 |
| 80 | DECODE | Allele-specific Deconvolution of Tumour DNA Methylation and Expression Data toReveal Underlying Cell Populations | 2016 |
| 81 | MESO-JBIR-102 | Development of the aza-Prins reaction; synthesis and biological evaluation of JBIR-102 | 2016 |
| 82 | ANGIO-IMAGE | ANGIO-tracer for immuno-PET imaging: a stratification and monitoring tool for anti-angiogenesis treatment | 2016 |
| 83 | SCoTMOF | Combined Chemo- and Radiotherapies by Controlling the Surface Chemistry of Truncated Metal Organic Framework Nanoparticles | 2016 |
| 84 | KILLCANCER | Nanobody-targeted photodynamic therapy to kill cancer | 2016 |
| 85 | EpigenomeProgramming | An experimental and bioinformatic toolbox for functional epigenomics and its application to epigenetically making and breaking a cancer cell | 2016 |
| 86 | HEAL-BY-MIRNA | microRNA replacement therapy for mature B cell neoplasias | 2016 |
| 87 | ICLUb | Regulation of DNA interstrand crosslink repair by ubiquitin. | 2016 |
| 88 | CLONCELLBREAST | CLONAL AND CELLULAR HETEROGENEITY OF BREAST CANCER AND ITS DYNAMIC EVOLUTION WITH TREATMENT | 2017 |
| 89 | Lumiblast | A paradigm shift in cancer therapy – using mitochondria-powered chemiluminescence to non-invasively treat inaccessible tumours | 2016 |
| 90 | NanoSCAN | Developing multi-modality nanomedicines for targeted annotation of oncogenic signaling pathways | 2016 |
| 91 | Gen-Epix | Genetic Determinants of the Epigenome | 2016 |
| 92 | Immune-senescence | Dual targeting of senescence and tumor immunity for cancer therapy | 2016 |
| 93 | TRANSREGULON | Structural biology of mammalian transcription regulation | 2016 |
| 94 | PCFENCM | Pan-cancer functional evaluation of non-coding DNA mutations | 2017 |
| 95 | CODECHECK | CRACKING THE CODE BEHIND MITOTIC FIDELITY: the roles of tubulin post-translational modifications and a chromosome separation checkpoint | 2016 |
| 96 | LeukaemiaTargeted | Selecting genetic lesions with essential function for patients' leukaemia in vivo as targets for precision medicine | 2016 |
| 97 | TENSION | Targeting replication stress recovery pathways in oncology | 2016 |
| 98 | CDK6-DrugOpp | CDK6 in transcription - turning a foe in a friend | 2016 |
| 99 | TNT-TUMORS | Therapeutic approaches to enhance innate immunity against Tumors | 2016 |
| 100 | INTEGRAL | Signal Integration by Gene Regulatory Landscapes | 2016 |
| 101 | GBM-CPP | Developing an anti-Myc cell-penetrating peptide for cancer treatment | 2016 |
| 102 | OMiProbe | Bio-optical probe technology for safe, fast and non-destructive cancer diagnosis | 2016 |
| 103 | Project ACT | Automated autologous cell therapy system | 2016 |
| 104 | Syndivia | Next generation drug conjugates for cancer treatment | 2016 |
| 105 | RIGVIR | Feasibility study for registration of medicine RIGVIR with the European Medicine Agency | 2016 |
| 106 | SEQUOIA-DD | Boosting productivity and performance in drug discovery with SEQUOIA - Semantic Query of Information Assets | 2016 |
| 107 | CoCa | Collagen in Cancer: from the regulatory fibril forming function of collagen V in development to its implication in tumor progression | 2016 |
| 108 | MIMICS | MicroRNA Isoforms for Molecular Interception of Cervical cancer using Self-samples | 2016 |
| 109 | ADC | Next-Generation Antibody-Drug Conjugates for safer and more effective cancer therapies | 2016 |
| 110 | TRANSMIT | TRANSlating the role of Mitochondria in Tumorigenesis | 2017 |
| 111 | TRACT | Training in Cancer Mechanisms and Therapeutics | 2016 |
| 112 | CATCH | Cancer: Activating Technology for Connected Health | 2016 |
| 113 | TRAIN | Tribbles Research and Innovation Network | 2016 |
| 114 | CohesinMolMech | Molecular mechanisms of cohesin-mediated sister chromatid cohesion and chromatin organization | 2016 |
| 115 | EPIPHARM | Development of a ncRNA DNA Methylation Kit for Treatment Guidance in Cancer of Unknown Primary | 2017 |
| 116 | ChromatinRemodelling | Single-Molecule And Structural Studies Of ATP-Dependent Chromatin Remodelling | 2017 |
| 117 | MMpredict | Validation of a personalised medicine tool for Multiple Myeloma that predicts treatment effectiveness in patients | 2016 |
| 118 | INSPIRED | Targeting IRE1 in disease | 2017 |
| 119 | THERACAN | Novel therapeutic strategies to treat pancreatic and lung cancer | 2017 |
| 120 | PICCOLO | Multimodal highly-sensitive PhotonICs endoscope for improved in-vivo COLOn Cancer diagnosis and clinical decision support | 2017 |
| 121 | HYPOXIMMUNO | Tackling the Achilles Heel of Immunotherapy: Validating imaging biomarkers and targeting the immunological niche of tumour hypoxia | 2016 |
| 122 | GlycoImaging | Imaging and detection of tumor-associated glycan structures on tumor cells | 2017 |
| 123 | PREVMETSYN | SMALL MOLECULES TO TREAT METABOLIC SYNDROME | 2017 |
| 124 | LungCARD | Blood test for clinical therapy guidance of non-small cell lung cancer patients | 2017 |
| 125 | Prometeo | Complete Automatization of Tissue Microarray Systems: Unleashing High-Throughput in Pathology Diagnosis, Prognosis and Anticancer Therapy | 2016 |
| 126 | SUMCASTEC | Semiconductor-based Ultrawideband Micromanipulation of CAncer STEm Cells | 2017 |
| 127 | TRANSPOS-X | Transposable elements, their controllers and the genesis of human-specific transcriptional networks | 2017 |
| 128 | SCUBA CANCERS | Finding the genetic causes of contagious metastases under the sea | 2017 |
| 129 | ONCOCHECK | A simple blood test for prognosis and monitoring of patients undergoing cancer therapy. | 2017 |
| 130 | SpheroPredict | A 3D advanced test for prediction of drug response in secondary liver cancer | 2017 |
| 131 | MAMLE | Understanding the mechanisms of human acute myeloid leukaemia (AML) evolution | 2017 |
| 132 | Curtana | Patented small molecule therapeutics that target cancer stem cells for the treatment of glioblastoma and other brain cancers | 2017 |
| 133 | LentiFactory | MAGIC (MAnufacturing of Gene delivery tools for Industrial and Clinical applications) | 2017 |
| 134 | PANTREAT | Pancreatic cancer as a treatment target of Dwarfbody-Therapeutics | 2017 |
| 135 | LIGER | Identification of novel substrates for ubiquitin ligases involved in cell cycle and cell migration | 2017 |
| 136 | BRECASTEM | Functional and Molecular Characterisation of Breast Cancer Stem Cells | 2017 |
| 137 | TRPLigDrugConj | TRPV1-targeted ligand-drug conjugates to treat prostate cancer | 2017 |
| 138 | MATESI | Multi-modal Approaches for Treatment and Evaluation of Swallowing Insufficiencies | 2018 |
| 139 | EXCITING-CT | Excellent lung cancer imaging and tumour identification using next generation computed tomography | 2017 |
| 140 | DREMATURE | DNA repair mechanisms and therapy resistance of BRCA2-deficient cancers | 2018 |
| 141 | BioMedBC | Molecular profiling of Bladder Cancer to support personalized medicine | 2017 |
| 142 | FocAd | Structural Studies on Focal Adhesions | 2017 |
| 143 | MiRCHOL | Mechanistic and therapeutic implications of microRNA deregulation for drug resistance in bile duct cancer | 2017 |
| 144 | SIOMICS | SIngle-cell multi-OMICs approach to study intra-tumour heterogeneity of soft tissue Sarcomas | 2017 |
| 145 | TeloChromatin | Dissecting the chromatin dynamics at telomeres during mouse pre-implantation development. | 2017 |
| 146 | Glyco-Platforms | Novel smart glyco-nanomaterials as targeted therapeutics. | 2017 |
| 147 | RTKPalm | Modulating and Profiling Receptor Tyrosine Kinase S-palmitoylation in Breast Cancer | 2017 |
| 148 | CINK | Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers | 2018 |
| 149 | METCLL | Discovery and validation of ‘epidrivers’ of cancer evolution and resistance to therapy | 2018 |
| 150 | RoNDBioCan | NLRP3 in cancer: Deciphering the role of NLRP3 in the DNA Damage response pathway | 2018 |
| 151 | IC_IL_EC_2017 | Investigating the effects of immunogenic chemoradiation in shaping the immune landscape of esophageal cancers | 2018 |
| 152 | CAR ART | Chimeric Antigen Receptor to generate Alloantigen-specific Regulatory T cells and promote allograft tolerance | 2017 |
| 153 | DSMT16 | Deciphering causes and consequences of inflammation in subtypes of sporadic intestinal cancer | 2018 |
| 154 | HEGEMONIC | HEpatocellular carcinoma GErmline MutatiONs ImpaCt (HEGEMONIC) | 2017 |
| 155 | ONCOGENEVOL | The evolutionary history of oncogenic and non-oncogenic papillomaviruses | 2017 |
| 156 | STARFISH DNA | Stalling the Replication Fork via the Impedimental Stabilization of Higher-order DNAs | 2017 |
| 157 | ONCOSYSTEMS | Phenotypic characterization of Liver-derived exosomes populations associated with liver metastasis in pancreatic cancers | 2017 |
| 158 | DUBs26S | Role of a novel proteasome-associated DUB – A boon for therapeutics | 2017 |
| 159 | INTUMORX | Elucidation of intratumoral heterogeneity in Kras-driven cancers | 2017 |
| 160 | CellTrack | Cellular Position Tracking Using DNA Origami Barcodes | 2017 |
| 161 | MINDED | MultIscale precision therapies for NeuroDEvelopmental Disorders | 2018 |
| 162 | FLUINEMS | Suspended Fluidic nanochannels as optomechanical sensors for single molecules | 2017 |
| 163 | Genome Biologics | Reducing the cost and increasing the speed of preclinical research in the pharmaceutical industry | 2017 |
| 164 | ReCAP | Repair capacity and genome diversity in mammals | 2017 |
| 165 | CATCH-U-DNA | Capturing non-Amplified Tumor Circulating DNA with Ultrasound Hydrodynamics | 2017 |
| 166 | CTC4BMP | Circulating tumor cells for tailoring BMP targeted therapies | 2017 |
| 167 | BRCA-ERC | Understanding cancer development in BRCA 1/2 mutation carriers for improved Early detection and Risk Control | 2017 |
| 168 | ULTIMATE | The best online drug discovery platform, Building the Ultimate chemical database for drug discovery | 2017 |
| 169 | u-PBeam | Microdosimetry study of a new radiation therapy method based on proton minibeams | 2017 |
| 170 | Photoclin | Advanced clinical photoacoustic imaging systems based on optical microresonator detection | 2017 |
| 171 | VDJtargeting | Engineering T cells and B cells for Immunotherapy using V(D)J recombination | 2017 |
| 172 | ELBA | European Liquid Biopsies Academy - Towards widespread clinical application of blood- based diagnostic tools | 2018 |
| 173 | DRIVE | Driving next generation autophagy researchers towards translation | 2017 |
| 174 | ImPRESS | Imaging Perfusion Restrictions from Extracellular Solid Stress | 2018 |
| 175 | NANONC | Nanomaterials in Oncology: Exploiting the Intrinsic Cancer-Specific Toxicity of Nanoparticles. | 2018 |
| 176 | NEOSETAC | New Selenium-based Targeted Nanocapsules to treat Breast Cancer | 2018 |
| 177 | SENSIT | Sensitivity of human tumors to T cell attack | 2017 |
| 178 | COLOSSUS | Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions | 2018 |
| 179 | INSITUMUT | Direct detection of cancer-causing mutations in tumour specimens | 2018 |
| 180 | MyPeBS | International Randomized Study Comparing personalized, Risk-Stratified to Standard Breast Cancer Screening In Women Aged 40-70 | 2018 |
| 181 | MTrix | Mechanical Targeting as an Integrative Approach for Personalized Nanomedicine | 2017 |
| 182 | CANCER-DC | Dissecting Regulatory Networks That Mediate Dendritic Cell Suppression | 2018 |
| 183 | GlycoEdit | New Chemical Tools for Precision Glycotherapy | 2017 |
| 184 | DualRP | Exploring cell interactions in the tumor microenvironment with dual ribosome profiling | 2018 |
| 185 | OMVCRC | Engineered bacterial Outer Membrane Vesicles (OMVs) for colorectal cancer immunotherapy | 2018 |
| 186 | OmnImmune | Manufacturing and testing of an allogeneic gamma delta T cell therapy for the treatment of cancer | 2017 |
| 187 | SDS-OmiProbe | Revolutionary opto-biological methodology for aggressive HER2 cancer | 2017 |
| 188 | Outsense Phase-1 | Toilet IoT sensor for medical monitoring and wellness tool | 2017 |
| 189 | CTC-MAL | Isolation of rare circulating tumor cells | 2018 |
| 190 | MEL-Interactions | An integrative approach for the exploration of melanoma genetic and immunological interactions | 2018 |
| 191 | STEMpop | Mechanisms of stem cell population dynamics and reprogramming | 2018 |
| 192 | MetaRegulation | Metabolic regulation of metastatic growth | 2018 |
| 193 | SI | Structural and functional characterization of the ICOS/ICOSL immune complex | 2018 |
| 194 | SaveHER | The inhibition of sorting proteins as a therapeutic avenue in HER2 positive breast cancer | 2018 |
| 195 | SOCIOCOMPLEXITY | Sociocomplexity — new paradigms for understanding complex group-level adaptation | 2018 |
| 196 | OE Scan | A next generation diagnostic device that effectively screens for breast cancer in all tissue types, without the use of ionising radiation | 2018 |
| 197 | ChemRAS | Chemical probing of transcriptional RAS effectors | 2019 |
| 198 | CRYOSTEM | Solvent free Cryopreservation of Hematopoietic Stem Cells | 2018 |
| 199 | NoMePaCa | Novel Metabolic Pathways in Cancer | 2018 |
| 200 | VENUSCANCER | Women’s cancers: do variations in patterns of care explain the world-wide inequalities in survival and avoidable premature deaths? | 2018 |
| 201 | MicroC | Agent-Based Modelling of Gene Networks to model clonal selection in the tumour microenvironment and predict therapeutic resistance | 2018 |
| 202 | NEOTERP | Development of novel synthetic strategies for the synthesis of bioactive meroterpenoids | 2018 |
| 203 | Target5LO | Targeting 5-lipoxygenase in the context of Acute Myeloid Leukemia | 2018 |
| 204 | SPeNTa-Brain | Synthetic Peptidic Nanovesicles for Targeting Paediatric Brain tumours | 2019 |
| 205 | MITIG | Addressing MITochondrial Import by Glioblastoma cells to rewire respiratory metabolism | 2019 |
| 206 | MetalloGutRepair | Identification of a Metalloproteinase-17-mediated cellular signalling circuit in intestinal regeneration and tumorigenesis | 2018 |
| 207 | GLYCANLIPO | Selective glycan recognition using molecularly imprinted liposomes | 2018 |
| 208 | Proteasome in cancer | Identification of the proteasome machinery targets in human cancer | 2018 |
| 209 | Gal3-BrainMets | A novel immunotherapy against brain metastasis: Anti-Galectin-3 | 2019 |
| 210 | ENGEMED | Simulating the dynamics of viral evolution: A computer-aided study toward engineering effective vaccines | 2018 |
| 211 | PathAutoBIO | Uncovering the pathway of DNA-induced autophagy and its biological functions in viral central nervous system infection | 2018 |
| 212 | 3D-Xist | 3D structure of the long non-coding RNA Xist by complementary cryo-electron tomography and single particle cryo-electron microscopy | 2018 |
| 213 | PNECtumor | Mechanisms regulating pulmonary neuroendocrine cell (PNEC) growth and tumorigenesis | 2019 |
| 214 | COLOVOC | Reliable and specific urinary biomarkers for colorectal cancer | 2019 |
| 215 | VulneraBAP1 | Mechanism and vulnerability of BAP1 loss in tumor metastasis | 2018 |
| 216 | UNNAMEd-2 | Unraveling the conceptional novel ADAM17 regulation by PP2A in metastasis formation. | 2019 |
| 217 | SKin SCiENCE | Skin Keratinocyte Stem CEll proliferatioN in field CancErisation | 2018 |
| 218 | PORTAL | Personalized oncology for refractory and relapsed lymphoma using humanized patient derived othotopic xenografts (ImmunePDOX) | 2018 |
| 219 | NANOBOTS | Tumor-Targeting Nanoengineered Bioorthogonal Technologies to Fight Metastatic Cancers | 2018 |
| 220 | FUCTURE | Fucosylated Clusterin: a novel mechanism of tumor escape from immune response | 2018 |
| 221 | METHYVIREVOL | Virocellular hybrids and epigenomic changes as driving factors of infection driven cancers. | 2019 |
| 222 | METAdiag | Detecting serious diseases due to abnormal cellular energetics | 2018 |
| 223 | DRAIOCHT | DRAIOCHT- A low-cost minimally invasive platform medical device for the treatment of disorders of the cardiovascular system. | 2019 |
| 224 | EDIT | Novel precision technological platforms to promote non-invasive early diagnosis, eradication and prevention of cancer relapse: proof of concept in the bladder carcinoma. | 2018 |
| 225 | cGEM | the Center for Genomics, Evolution and Medicine | 2018 |
| 226 | SENCAN | Senescence therapy for cancer | 2018 |
| 227 | REPLISTRESS | DNA Replication: From Physiology to Replication Stress in Human Cancer | 2018 |
| 228 | SUMMIT | Stepping Up mRNA Mutanome Immunotherapy | 2018 |
| 229 | GDS | A safe and effective non-surgical and reversible procedure for weight loss | 2018 |
| 230 | NovaTests | The first predictive test for radio-sensitivity. A step towards an improved and personalised radiation therapy cancer treatment. | 2018 |
| 231 | EpiGlioT | Epigenetic Glioblastoma Therapeutics | 2018 |
| 232 | SCOPIO | High-resolution, all-digital microscope that applies computational methods to bring revolutionary benefits of digital microscopy to small and medium sized laboratories | 2018 |
| 233 | FOCALISE | Facile Oxygen Consumption Assay for Lacteal Industry and Spoilage Evaluation | 2018 |
| 234 | ONCORED | An unrivalled medical device based on red- light photo biomodulation to prevent, improve and remove oral mucositis and dermatitis chemo radio induced as a side effect of cancer treatment | 2018 |
| 235 | SenolT | Fast and effective diagnostic test for the early detection of residual tumours to prevent cancer recurrence | 2018 |
| 236 | SYST-iMYC | Development of an effective and safe systemic Myc inhibitor for the treatment of multiple cancer types. | 2018 |
| 237 | PML-THERAPY | HARNESSING PML NUCLEAR BODIES FOR LEUKAEMIA THERAPY | 2019 |
| 238 | CL-IO | Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis | 2018 |
| 239 | RNADIAGON | Excellence in research and development of non-coding RNA DIAGnostics in ONcology | 2019 |
| 240 | EPIC | Enabling Precision Immuno-oncology in Colorectal cancer | 2018 |
| 241 | EPI-X4Health | Therapeutic potential of optimized derivatives of an endogenous CXCR4 antagonist for the treatment of cancers and inflammatory diseases | 2018 |
| 242 | INTEGRATA | Integrating chemical and biological approaches to target NAD production and signaling in cancer | 2018 |
| 243 | WHILYAS | Wound healing ILYA-style | 2018 |
| 244 | FIBROHALT | Advancing a novel peptide-based therapeutic for pancreatic cancer | 2018 |
| 245 | DCDP | Digital Cancer Diagnosis Platform | 2018 |
| 246 | PRIMAGE | PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers | 2018 |
| 247 | CONQR | Translation and Commercialization of a QSOX1-inhibitory Antibody Targeting the Tumor Microenvironment in Breast Cancer | 2018 |
| 248 | GLIOVACC | Augmenting and broadening T-cell responses to glioblastoma - therapeutic vaccine platform based on HCMV expressing NKG2D ligands | 2018 |
| 249 | CONAN II | CONAN II - COmplete Nucleic acid ANalysis at genome scale at ultra-high throughput Phase 2 | 2018 |
| 250 | PedSarc | Targeting genetic and epigenetic mechanisms in pediatric sarcomas. | 2019 |
| 251 | Nevada | Diagnostics device for rapid testing of prostate cancer at Point-of-care | 2018 |
| 252 | ONCOBIOME | Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. | 2019 |
| 253 | SELNET | Sarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary network | 2019 |
| 254 | AI-MICADIS | Artificial Intelligence System for Multi-Cancer Detection Support | 2019 |
| 255 | ENDOMICS | Raman Endoscopic Proteo-lipidomics of Bladder Cancer | 2019 |
| 256 | iNANOVAC4CANCER | BIOHYBRID AND BIODEGRADABLE NANOVACCINES FOR CANCER IMMUNOTHERAPY | 2019 |
| 257 | incPRINT-DRUG | incPRINT as a platform for RNA-targeted drug discovery | 2019 |
| 258 | FRINGE | Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies | 2019 |
| 259 | Capsulight | The first ingestible capsule for eradicating Helicobacter pylori infection through photodynamic therapy | 2019 |
| 260 | ONCOFUM | Integrating the tissue-specificity and chronology of hereditary renal cancer predisposition | 2019 |
| 261 | MyPal | MyPal: Fostering Palliative Care of Adults and Children with Cancer through Advanced Patient Reported Outcome Systems | 2019 |
| 262 | Metachip | A pan-cancer diagnostic platform based on nanobiotechnology and machine learning for simple and accessible early cancer detection | 2019 |
| 263 | iPC | individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology | 2019 |
| 264 | CancerFingerPrints | Identification of nano-mechanical fingerprints as a biomarker for cancer treatment prognosis | 2019 |
| 265 | POCON | Proof-of-Concept of a nanobody targeting Osteopontin to inhibit colorectal cancer development | 2019 |
| 266 | IntratumoralNiche | Defining heterocellular signalling within the intratumoral stem cell niche of colorectal cancer | 2019 |
| 267 | PATRES-MDS | Pathogenesis and treatment of splicing factor mutant myelodysplastic syndromes | 2019 |
| 268 | IMaP | Imaging tumor vessels as a marker for p53 mutation status in cancer | 2020 |
| 269 | Biosensor Design | Engineering Chemotactic Biosensors for a Diverse Spectrum of Metastatic Markers | 2020 |
| 270 | Kinaddict | Vulnerability of esophageal cancer to their addiction to kinase activities: evaluation and prediction of eSCC tumors responsiveness to kinase inhibitors. | 2019 |
| 271 | RESIST3D | Targeting drug resistance in ovarian cancer through large-scale drug-response profiling in physiologically relevant cancer organoids | 2020 |
| 272 | Centromere Stability | Mechanisms that maintain centromere DNA repeats stability in human cells. | 2020 |
| 273 | THERMOGUIDE | Optimizing delivery and effectiveness of chemotherapy in breast cancer patients using thermotherapy under image-guidance | 2019 |
| 274 | EOBRECA | Differential Roles of Estrogens in Obesity-mediated ER+ Breast Cancer Development | 2019 |
| 275 | MacrophInt | Targeting integrin signaling in tumour-associated macrophages to combat cancer progression and resistance | 2019 |
| 276 | PB_dormancy | Insertional mutagenesis to identify molecular mechanisms of breast cancer dormancy and metastasis | 2020 |
| 277 | MechTransition | Regulatory mechanisms controlling a new mechanical Epithelial to Mesenchymal Transition in zebrafish | 2020 |
| 278 | UreaCa | Deciphering the metabolic roles of the urea-cycle pathway in carcinogenesis for improving diagnosis and therapy | 2019 |
| 279 | CancerADAPT | Targeting the adaptive capacity of prostate cancer through the manipulation of transcriptional and metabolic traits | 2019 |
| 280 | IMMUcan | Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts | 2019 |
| 281 | Biochip-images | A Breast Cancer Biomarker Point of CarePOCDiagnostic Platform Integrating Dual-Functionalized Nanoparticle for Magnetic Gradient Ranking and Electrochemical Sensing | 2019 |
| 282 | STREAM | Smart Textile foR hEAlth Monitoring | 2020 |
| 283 | FUNTRICAN | Functional analysis of thyroid hormone nuclear receptors TRs in human Intestinal Cancer stem cells | 2019 |
| 284 | TargetDUBs | Targeting ubiquitin processing in cancer and fibrosis: novel probes for the Ubiquitin Carboxy-Terminal Hydrolases | 2019 |
| 285 | SUPERBRAIN | Magneto-Plasmonic, Raman active Nanocapsules for Superior Pediatric Brain Cancer Therapy | 2020 |
| 286 | MONET | Merkel cell polyomavirus Oncogenic Network | 2019 |
| 287 | OCTAV | A novel approach to non-invasive and personalized skin cancer diagnosis | 2019 |
| 288 | CB-103 | First effective targeted therapy for T-cell acute lymphoblastic leukemia (T-ALL) and other NOTCH pathway driven cancers | 2019 |
| 289 | GLASST | Global and Local Health Impact Assessment of Transport: methods for prioritising model development | 2019 |
| 290 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
| 291 | EPICAN | Inhibiting tumor cell plasticity by targeting the epigenome in breast cancer | 2020 |
| 292 | MetEpiC | P53-dependent Metabolic and Epigenetic Reprogramming in Carcinogenesis | 2020 |
| 293 | MS | Unravelling the molecular and cellular mechanism of metastasis | 2020 |
| 294 | T-NHL SUPRESSORS | Tumor suppressor pathways counteracting oncogenic immune receptor signaling in T-Cell Lymphoma | 2019 |
| 295 | RASImmune | Targeting RAS driven tumour immune evasion | 2019 |
| 296 | APAC | Advanced Pain Control – An innovation in pain control for those suffering from secondary bone cancer | 2019 |
| 297 | ImmunoGrow | Making life-saving cancer therapies more widely available by simplifying production processes, reducing costs and enhancing patient safety through its patent-protected biomimicking mesh material. | 2019 |
| 298 | FRAME | FRAME - tumor genome-based personalized anti-cancer vaccines off-the-shelf | 2019 |
| 299 | IRIS Phase-1 | A revolutionary blood test to easily diagnose and prevent deadly complications of organs and tissue transplants. | 2019 |
| 300 | IL7RsignaTHER | Antibody-based IL-7R targeted therapies | 2020 |
| 301 | IMMUNOTRAP | Diagnosis test for immuno-oncology therapies. | 2019 |
| 302 | AntiHelix | DNA helicases in genome maintenance: from molecular and cellular mechanisms to specific inhibitors as potential drugs | 2019 |
| 303 | SECRET | Exploitation of the SECRETory pathway for cancer therapy to address European research | 2019 |
| 304 | Mirnagreen | First scalable food-grade technology for the direct extraction and purification of miRNAs-rich extracts from plants | 2019 |
| 305 | NEUcrest | Training European Experts in Multiscale Studies of Neural Crest Development and Disorders: from Patient to Model Systems and Back again. | 2019 |
| 306 | PeptiCHIP | PEPTICHIP: Streamlined identification of tumour neoantigens for personalised anti-cancer immunotherapy | 2019 |
| 307 | PAVE | A nanovaccine Approach for the treatment of Pancreatic Cancer | 2019 |
| 308 | HIL PT System | A revolutionary, cost effective, ultra-compact proton therapy system for cancer treatment | 2019 |
| 309 | CSI AurkA-MYC | Conformational Shift Inducers (CSI): An atomistic level investigation of Aurora kinase A (AurkA)–MYC interaction and its distortion by CSI compounds | 2019 |
| 310 | ConflictResolution | Transcription-replication conflicts in disease and development | 2020 |
| 311 | PROT-RESIST | Toward the Commercialization of a Proteolytically Resistant APPI Variant for Inhibiting Metastasis in Prostate and Pancreatic Cancer | 2019 |
| 312 | QUALITOP | Monitoring multidimensional aspects of QUAlity of Life after cancer ImmunoTherapy - an Open smart digital Platform for personalized prevention and patient management | 2020 |
| 313 | MaxONCO | A cancer vaccine to boost body’s natural defences to fight chordoma and head and neck cancer | 2020 |
| 314 | NanoPD_P | High throughput multiplexed trace-analyte screening for diagnostics applications | 2020 |
| 315 | SMART UV | Intelligent Ultraviolet (UV) Radiation Filters | 2019 |
| 316 | RARITY | RAtional design of canceR ImmunoTherapY: one size does not fit all | 2019 |
| 317 | Cancersensing | A multi-cancer screening platform for fast and accurate early stage cancer detection from urine samples | 2019 |
| 318 | STI-001 | Turn Cancer Immunotherapy Effective in Most Patients | 2019 |
| 319 | PARPinhibit | A systems biology approach to tackle PARP-inhibitors resistance and identify novel therapeutic targets to overcome it | 2020 |
| 320 | ESPACE | Human Cell Atlas of the Pancreas | 2020 |
| 321 | Instand-NGS4P | Integrated and standardized NGS workflows for Personalised therapy | 2020 |
| 322 | DDREAMM | Dna Damage REsponse: Actionabilities, Maps and Mechanisms | 2020 |
| 323 | inhibiTOR | Novel selective mTORC1 inhibitors | 2020 |
| 324 | M6AQuantKit | Development and commercialization of kit for quantitative interrogation of a key RNA modification | 2020 |
| 325 | PHYRIST | Physiological roles of the Ribotoxic Stress Response | 2020 |
| 326 | METABOLIGHT | Optical imaging platform to unravel metabolic reprogramming of cancer: a path for improved treatments | 2020 |
| 327 | BRCAstem | Monitoring cancer stem cell dynamics and therapeutic response in BRCA2-deficient breast tumour cells | 2020 |
| 328 | FBC predisposition | Unraveling novel Familial Breast Cancer (FBC) predisposition genes. | 2020 |
| 329 | TGF-BTB | Transforming Growth Factor – Bench To Bedside. Towards a better understanding of TGF-β isoform specific signalling in health and disease | 2020 |
| 330 | GLoopID | Mechanisms underlying regulation and removal of G-quadruplex/R-loop transcription-replication conflicts | 2021 |
| 331 | Immuno-Predictor | Mechanical Biomarkers for Prediction of Cancer Immunotherapy | 2020 |
| 332 | SmartSAST | Non-covalent photoresponsive tags for photoacoustic imaging: Giving voice to living matter | 2020 |
| 333 | RCC_Evo | Modelling the Predictability and Repeatability of Tumour Evolution in Clear Cell Renal Cell Cancer | 2020 |
| 334 | ICG68-PROG | Imaging of c-Met aberrant cancers with Gallium-68 chelators for positron emission tomography | 2020 |
| 335 | ROSETTA | Deciphering the Role of aberrant glycOSylation in the rEsponse to Targeted TherApies for breast cancer | 2020 |
| 336 | HypoCyclo | Multifunctional Polymeric Cyclodextrin Nanocarriers As Novel Triple-Negative Breast Cancer Treatment: A Versatile Photo-Chemotherapy Bypassing Hypoxic Conditions | 2020 |
| 337 | SecondCANCERinKIDS | What causes therapy-related malignancies in childhood cancer survivors? Dissecting the etiology of second cancers | 2020 |
| 338 | TARGETOF | Mass cytometry nanotools for intracellular target engagement. Towards precision medicine. | 2021 |
| 339 | RASATaC | Regulating RAS Activity to Target RAS-Driven Cancers | 2020 |